Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Suicide

• Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
• Psychopharmacological Treatment of Emotional Distress
• iTBS+D-Cycloserine for Youth Suicide
• Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
• Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
• Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
• Assessing SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
• Ketamine Treatment of Youth Suicide Attempters
• An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy
• A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
• Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
• Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
• Ketamine + Cognitive Training for Suicidality in the Medical Setting
• Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
• Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
• Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
• Opiate Suicide Study in Patients With Major Depression
• Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
• Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents
• ED Treatment of Suicidal Patients With Ketamine Infusion
• Ovarian Hormones and Suicide Risk
• Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Partici
• 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participa
• 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participa
• Sequential Therapy for the Treatment of Severe Bipolar Depression.
• Long-term Prognosis of Cluster Headache: a Retrospective Cohort Study
• 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression
• Neurobiology of Suicide
• The Impact of Ketamine on the Reward Circuitry of Suicidal Patients
• A Study to Decrease Suicidal Thinking Using Ketamine
• Intranasal Ketamine for Late-Life Depression and Suicidal Ideation
• A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide
• Ketamine for Depression and Suicide Risk
• Lithium for Suicidal Behavior in Mood Disorders
• The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study
• Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial
• Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
• Administration of Donor T Cells With the Caspase-9 Suicide Gene
• Ketamine for Low Mood States in the ER
• Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder
• Suicide Prevention by Lithium - the Lithium Intervention Study
• Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
• Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide
• Treatment of Adolescent Suicide Attempters (TASA)